🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A busy few months of travel for the Cancer Discovery team kicks off with the l AACR Special Conference on Advancing Precision Medicine - looking forward to learning a lot at talks and discussions chaired by AACR President Lillian L. Siu David Hyman Eli Van Allen and Lillian Siu #AACRRWD20

Excited to be in San Diego for the AACR conference on Advancing Precision Medicine Drug Development. I look forward to joining my co-chairs—David Hyman, Eli Van Allen, and Lillian Siu—as well as leaders in academia, government, industry, finance, and insurance. #AACRRWD20

Just published in Cancer Discovery to conicide with #AACRRWD20: Characteristics and outcome of AKT1 E17K–mutant #BreastCancer defined through AACR Project GENIE, a clinicogenomic registry Lillian Smyth Bastien Nguyen David Hyman @sloan_kettering #RealWorldData cancerdiscovery.aacrjournals.org/content/early/…

In addition to being a terrific meeting, AACR "Advancing Precision Medicine Drug Development" is also piloting a new mandatory dress code policy 🙄 Barry S. Taylor Alison Schram Eli Van Allen AACR President Lillian L. Siu #AACRRWD20

Defining outcomes in rare genomically-defined populations critical for advancing therapy. AACR Project GENIE proof-of-concept work by Lillian Smyth et al out, timed with #AACRRWD20 meeting! Thanks to Cancer Discovery for recognizing value in this new type of pub cancerdiscovery.aacrjournals.org/content/early/…

Very interesting plenary session and panel discussion on "Novel Drug Development Approaches / Drugging Difficult Targets" this morning at #AACRRWD20. Thanks to session chair David Hyman and to Jose Baselga, Levi Garraway, and Jeff Engelman for participating.

Great discussion on exciting new approaches to drugging the difficult targets in cancer from old friends/big machers in pharma - Drs. Baselga, Garraway, Engleman, and Hyman AACR #AACRRWD20

Really looking forward to the day when PONV is a significant concern for anesthesiologists and our patients again!

Before my amazing wife became a #COVID19 doc this week, she was a more than full time clinical anesthesiologist 😷 who somehow found the time to run a rigorously designed 140 patient RCT. A tireless ~5-year effort with practice-changing results. I simply could not be more proud🥰

The AACR Annual Report, which outlines the AACR’s programs and initiatives over the past year, is now available. annualreport2019.aacr.org

I didn’t even remember this and certainly would not have predicted this would be a featured clip. But it was real. And devastating. #COVID19 thanks Ron Suskind for capturing it

Love that he highlighted four amazing leaders who really saved Weill Cornell Medicine. Lindsay Lief @NIvascuMD Maria Karas and Kelly Griffin. Tony Hollenberg John P. Leonard, MD

While manning the front lines of the pandemic during the spring NYC wave, Jaime Hyman also found time to help contribute to our understanding of #COVID19

Numb from news this morning of José Baselga's passing. Larger than life and a true giant of the field, he helped transform oncology care and saved countless lives. Personally, José also played a central role in my career. I will miss him dearly.

Looking forward to celebrating the incredible life of our colleague and my former mentor, José Baselga, later today. See you there 👇

It is my honor to represent the AACR in acknowledging the José's life and legacy. His dynamic leadership, innovative mind, and generous mentorship made a lasting impact on the cancer research community.